Penetrium Bioscience페니트리움바이오
187660 · KOSDAQ · ₩187660 · 페니트리움바이오
₩6,170▼ ₩490 (7.36%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 19, 2026Open on DART
Predicted impact: Low
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 14, 2026Open on DART
Predicted impact: Low· Actual: −8.4% vs sector, volume 0.2× normal (5 trading days)
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 9, 2026Open on DART
- Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Sep 9, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 4, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 4, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (재발성 또는 불응성 진행성 고형암 임상 2a상 임상시험계획 숭인)Sep 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 2, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 27, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Aug 13, 2026Open on DART
- Securities Issuance Results Report증권발행실적보고서Aug 13, 2026Open on DART
- [Amended] Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)[기재정정]유상증자또는주식관련사채등의청약결과(자율공시)Aug 12, 2026Open on DART
- Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의청약결과(자율공시)Aug 11, 2026Open on DART
- Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의청약결과(자율공시)Aug 7, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 6, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (재발성 또는 불응성 진행성 고형암 임상 2a상 IND신청)Aug 4, 2026Open on DART
- Final Determination of Issue Price for Rights Offering유상증자최종발행가액확정Aug 3, 2026Open on DART
- Amended: Prospectus[기재정정]투자설명서Aug 3, 2026Open on DART
- Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Aug 3, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 3, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 22, 2026Open on DART
- Amended: Investor relations (IR) event[기재정정]기업설명회(IR)개최Jul 7, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 3, 2026Open on DART
- Ex-Rights Date (Rights Offering)권리락 (유상증자)Jun 26, 2026Open on DART
- Determination of Issue Price for First Tranche of Rights Offering유상증자1차발행가액결정Jun 26, 2026Open on DART
- Prospectus투자설명서Jun 26, 2026Open on DART
- Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Jun 26, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jun 26, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 18, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (불응성/재발성 고형암 대상 펨브롤리주맙과 PenetriumTM 병용요법 1상 임상시험계획 변경승인)Jun 17, 2026Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(지분증권)Jun 11, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jun 11, 2026Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(지분증권)May 27, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)May 27, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) ((불응성/재발성 고형암 대상 펨브롤리주맙과 PenetriumTM 병용요법 1상 임상시험계획 변경승인 신청))May 13, 2026Open on DART
- Securities registration statement증권신고서(지분증권)Apr 30, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Apr 30, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 26, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Mar 17, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 12, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Mar 10, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 6, 2026Open on DART
- Notice of Company Name Change상호변경안내Mar 6, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 6, 2026Open on DART
- Audit report submitted감사보고서제출Feb 26, 2026Open on DART
- Added attachment: Annual report (Dec 2025)[첨부추가]사업보고서 (2025.12)Feb 26, 2026Open on DART
- Exchange inquiry about a news report or price move조회공시요구(현저한시황변동)에대한답변(미확정)Feb 20, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Feb 20, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: Penetrium Bioscience / 페니트리움바이오 / 187660 / KRX:187660
Source: KRX statistical information